# Feline Hypertension: Target Organ Damage and Monitoring Protocols


## Key Takeaways

- Feline hypertension is a common geriatric condition, frequently co-occurring with chronic kidney disease (CKD) and hyperthyroidism, and its sustained elevation causes significant damage to ocular, renal, cardiac, and cerebrovascular systems.
- Diagnosis relies on serial systolic blood pressure measurements using Doppler or oscillometric techniques, with a minimum of five to seven readings per session, and a systolic pressure consistently above 160 mmHg warrants treatment, especially if target organ damage is present.
- Ocular target organ damage, manifesting as hypertensive retinopathy, retinal edema, tortuous vessels, hemorrhage, or detachment, is a clinically apparent consequence and a critical indicator for prompt antihypertensive intervention.
- Renal damage is bidirectional; hypertension accelerates CKD via glomerular capillary hypertension and proteinuria, while CKD can exacerbate hypertension through mechanisms like the renin-angiotensin-aldosterone system.
- Monitoring protocols for treated patients involve rechecking blood pressure within 7-14 days of dose adjustments, with regular funduscopic examinations and assessment of renal function (serum creatinine, SDMA, UPC) to evaluate treatment efficacy and detect progression of target organ damage.
- Amlodipine besylate is the primary therapeutic agent for feline hypertension, with dosage individualized based on patient response and target blood pressure, typically aiming for a systolic pressure below 160 mmHg, and ideally below 150 mmHg in cats with proteinuric CKD.

---

Feline systemic hypertension is a common disease of older cats, frequently diagnosed alongside chronic kidney disease and hyperthyroidism, although primary hypertension is also reported. The clinical consequences of sustained high blood pressure are severe and relate to damage in the eye, heart and vasculature, brain, and kidneys. Early diagnosis and appropriate therapeutic management reduce the morbidity associated with this condition, yet routine blood pressure monitoring is performed infrequently in practice, leading to underdiagnosis. This article provides a diagnostic-reasoning framework for veterinary students and practitioners, covering the pathophysiology of hypertensive target organ damage, the clinical syndromes that result, and systematic monitoring protocols for at-risk and treated patients. It answers the question of how to identify hypertension before catastrophic injury occurs and how to verify that treatment is achieving its protective goals.

The geriatric cat appears most susceptible to the development of systemic hypertension, and monitoring of systolic blood pressure is often advocated as part of a routine health screen in cats over nine years of age. By 15 years of age, the probability of having at least one of the two most common concurrent diseases, renal disease and hyperthyroidism, is high. Because well-cared-for cats are living longer, optimal long-term management of hypertension in patients with concurrent disease is an issue of increasing clinical importance. Clinical signs may not be apparent to owners until severe target organ damage is present, and blood pressure monitoring in cats with chronic kidney disease remains infrequently performed.

## At a Glance

| Parameter | Clinical Relevance | Monitoring Guidance |
|---|---|---|
| Systolic blood pressure | Primary measurement used for diagnosis and treatment monitoring | Doppler or oscillometric techniques, multiple readings per visit |
| Ocular fundus | Retinopathy, hyphaema, retinal detachment indicate target organ damage | Funduscopic examination at diagnosis and each recheck |
| Renal function | Hypertension and CKD have an intermingled cause-and-effect relationship | Serum creatinine, SDMA, urinalysis, UPC at diagnosis and regularly thereafter |
| Urine protein-to-creatinine ratio | Proteinuria is an independent risk factor for progression and mortality in CKD | Measure at diagnosis, after blood pressure control, and at intervals |
| Cardiac assessment | Hypertensive cardiac changes detectable on auscultation and imaging | Thoracic auscultation at each visit, echocardiography if murmur or arrhythmia |
| Neurologic status | Seizures, vestibular signs, or behavioral change may indicate hypertensive encephalopathy | Neurologic examination at diagnosis and with any clinical change |
| Treatment response | Amlodipine is the treatment of choice, dose varies between individuals | Recheck blood pressure within 7 to 14 days of treatment change |

## Pathophysiology of Hypertensive Target Organ Damage

Sustained systemic hypertension damages small arterioles through mechanical stress on the vascular endothelium, leading to mural thickening, hyalinosis, and loss of autoregulatory capacity. Organs with high blood flow and limited autoregulatory reserve, namely the eye, kidney, brain, and heart, are most vulnerable. The pattern of injury in cats differs from that in dogs and humans, with ocular and renal damage predominating clinically. The relationship between chronic kidney disease and hypertension is bidirectional: renal disease can drive hypertension through reduced sodium excretion and activation of the renin-angiotensin-aldosterone system, while hypertension accelerates renal injury through glomerular capillary hypertension and proteinuria. This intermingled cause-and-effect relationship significantly impacts the welfare of affected cats, and blood pressure monitoring with institution of effective antihypertensive treatment where indicated is crucial in effective management of the feline CKD patient.

### Ocular Target Organ Damage

The eye is the most clinically apparent target organ. Hypertensive choroidopathy produces retinal edema, tortuous retinal vessels, and perivascular hemorrhage. As blood pressure rises further, exudative retinal detachment and hyphaema can occur, and cats may present with sudden-onset blindness. In one series of 30 hypertensive cats, ocular lesions were a common finding at diagnosis, and blindness was the presenting complaint in a substantial proportion. Funduscopic examination is therefore essential to the diagnosis of systemic hypertension, and the presence of hypertensive retinopathy confirms that blood pressure has been sufficiently elevated to cause structural injury.

### Renal Target Organ Damage

The kidney is both a cause and a victim of hypertension. Glomerular capillary hypertension damages the filtration barrier, producing proteinuria, and proteinuria is an independent risk factor for progression and mortality in cats with chronic kidney disease. Hypertension also drives tubulointerstitial fibrosis and nephron loss, accelerating the decline in renal function. In cats with CKD, blood pressure monitoring and institution of effective antihypertensive treatment, where indicated, is crucial in effective management of the patient. The ISFM consensus guidelines identify proteinuria as a key parameter to monitor alongside blood pressure, and the urine protein-to-creatinine ratio should be measured at diagnosis and after blood pressure control is achieved.

### Cardiovascular and Cerebrovascular Target Organ Damage

Hypertension increases left ventricular afterload, producing concentric left ventricular hypertrophy and diastolic dysfunction. Auscultation may reveal a gallop rhythm or systolic murmur, and echocardiography can document increased left ventricular wall thickness. Hypertensive encephalopathy results from cerebral arteriolar damage and loss of autoregulation, manifesting as seizures, vestibular signs, behavioral change, or stupor. These signs are often subtle and may be attributed to other diseases of older cats, so a high index of suspicion is required in any geriatric cat with new neurologic signs.

## Blood Pressure Measurement Technique

Accurate measurement is the foundation of diagnosis and monitoring. The ISFM consensus guidelines recommend that systolic blood pressure be measured using Doppler or oscillometric techniques, with the Doppler method generally considered more reliable in cats. The cat should be allowed to acclimatise to the examination room for several minutes before measurement. The cuff should be placed on a forelimb or the tail, and its width should be approximately 30 to 40 percent of the limb circumference. A minimum of five to seven readings should be taken, and the first reading is often discarded because it tends to be elevated by the stress of handling. The average of the remaining readings is used for clinical decision-making.

White-coat hypertension, a transient elevation in blood pressure caused by the stress of the clinic visit, is a recognized phenomenon in cats. Obtaining accurate measurements in patients that are anxious, fractious, or uncooperative remains a significant issue in feline medicine, and confident analysis of results from these patients is difficult. If the cat is distressed, the measurement should be abandoned and repeated at a later visit, or the owner may be trained to measure blood pressure at home, although this is not universally practical.

## Classification of Hypertension and Risk Stratification

The ISFM consensus guidelines classify hypertension according to systolic blood pressure and the presence of target organ damage. Risk of target organ damage increases with systolic blood pressure, and the presence of ocular, renal, cardiac, or neurologic injury modifies the urgency of intervention. Cats with systolic blood pressure consistently above the threshold for intervention and evidence of target organ damage require immediate treatment, while cats with borderline elevations and no detectable damage may be monitored and rechecked. The guidelines emphasize that a single elevated reading is insufficient for diagnosis, and that blood pressure should be measured on multiple occasions before treatment is initiated, unless severe target organ damage is present.

## Monitoring Protocols in the Treated Patient

Once antihypertensive treatment is initiated, the goal is to reduce systolic blood pressure below the target threshold while avoiding hypotension and preserving renal function. Amlodipine besylate is the treatment of choice and is effective in the majority of cats, but the dose needed to successfully manage hypertension varies between individuals. Some cats require long-term adjuvant therapy, and occasionally additional therapy is necessary for emergency management. Blood pressure should be rechecked within 7 to 14 days of any dose change, and the cat should be examined for evidence of target organ damage at each recheck. Funduscopic examination should be repeated to document resolution of retinal lesions, and renal parameters, including serum creatinine and urine protein-to-creatinine ratio, should be monitored to detect progression of CKD or adverse effects of blood pressure reduction.

## Diagnostic Assessment Sequence for Suspected Hypertension

The diagnostic workup begins with confirming that an elevated blood pressure reading represents true systemic hypertension instead of situational or white-coat hypertension. The [ISFM consensus guidelines on feline hypertension](https://pubmed.ncbi.nlm.nih.gov/28245741/) recommend that a diagnosis of hypertension be based on serial measurements obtained under standardized conditions, with the cat allowed to acclimatise to the consultation room for 5 to 10 minutes before any readings are taken. A minimum of five to seven consecutive readings should be obtained, and the average of these readings, after discarding the highest and lowest values, forms the basis for clinical decision-making.

When the first measurement session yields a systolic blood pressure above 160 mmHg, the clinician must decide whether to repeat measurements immediately or schedule a second visit. The decision depends on the magnitude of elevation and the presence of target organ damage. A cat with a systolic pressure of 180 mmHg or higher, particularly one with fundic lesions, requires same-session repeat measurement and prompt intervention if the elevation persists. A cat with borderline elevation between 160 and 179 mmHg and no detectable target organ damage can be rechecked within 1 to 2 weeks, provided the owner can be instructed to monitor for behavioral changes such as disorientation, reduced vision, or altered interaction with the environment.

The diagnostic sequence proceeds in a fixed order. Blood pressure measurement should occur before other procedures that may cause stress, including venepuncture, cystocentesis, and ophthalmologic examination with bright light. The cat should be positioned in a quiet room with minimal handling. The [feline hypertension diagnosis and management guidance from Stepien](https://pubmed.ncbi.nlm.nih.gov/21215947/) emphasizes that Doppler ultrasonography is generally preferred over oscillometric devices in fractious cats because the Doppler technique tolerates movement better and requires less restraint. Oscillometric devices may be more accurate in calm cats but tend to underestimate blood pressure when the animal is moving or when the cuff is incorrectly sized.

Cuff selection follows a standardized protocol. The cuff width should approximate 30 to 40 percent of the limb circumference, and the cuff should be placed on the forelimb or hindlimb at the level of the mid-radius or mid-tibia. The same limb and cuff position should be used for every measurement in a given cat to allow longitudinal comparison. The [ISFM consensus guidelines](https://pubmed.ncbi.nlm.nih.gov/28245741/) recommend that the measurement site be recorded in the medical record so that subsequent measurements are directly comparable.

## Interpreting Blood Pressure Categories in Context

Blood pressure classification in cats uses systolic pressure as the primary criterion because diastolic measurements are less reliable with indirect techniques. The [ISFM consensus guidelines](https://pubmed.ncbi.nlm.nih.gov/28245741/) define risk categories that integrate blood pressure with the presence or absence of target organ damage. A systolic pressure below 150 mmHg is considered normotensive. Readings between 150 and 159 mmHg are classified as borderline hypertension, and the decision to treat depends on the presence of concurrent disease such as chronic kidney disease or hyperthyroidism, as well as the trend over serial measurements.

Systolic pressure between 160 and 179 mmHg constitutes hypertension, and treatment is recommended when target organ damage is present or when the cat has a condition that predisposes to hypertensive injury. Systolic pressure of 180 mmHg or higher is classified as severe hypertension and warrants treatment regardless of whether target organ damage is detectable. The [review of feline comorbidities by Lawson and Jepson](https://pubmed.ncbi.nlm.nih.gov/34428941/) notes that the relationship between chronic kidney disease and hypertension is bidirectional, and that proteinuria serves as an independent risk factor for progression and mortality in cats with both conditions. This means that a cat with chronic kidney disease and a systolic pressure of 155 mmHg may warrant treatment earlier than a healthy cat with the same reading.

| Blood Pressure Category | Systolic Range (mmHg) | Target Organ Damage Present | Recommended Action |
|-------------------------|----------------------|-----------------------------|---------------------|
| Normotensive | <150 | No | Routine monitoring per risk profile |
| Borderline | 150 to 159 | No | Recheck in 1 to 2 weeks, treat if CKD, hyperthyroidism, or proteinuria present |
| Borderline | 150 to 159 | Yes | Treat and monitor |
| Hypertensive | 160 to 179 | No | Treat if risk factors present, recheck in 1 week if untreated |
| Hypertensive | 160 to 179 | Yes | Treat and monitor closely |
| Severely hypertensive | ≥180 | Any | Treat immediately, recheck within 3 to 7 days |

The presence of ocular target organ damage changes the urgency of intervention. A cat with hypertensive retinopathy, including retinal hemorrhage, focal retinal detachment, or papilloedema, requires immediate treatment even if the measured blood pressure is only mildly elevated. The [clinical findings from Elliott and colleagues](https://pubmed.ncbi.nlm.nih.gov/11303854/) in a series of 30 hypertensive cats demonstrated that systolic blood pressure at diagnosis averaged above 200 mmHg in most cases, and that successful treatment with amlodipine reduced systolic pressure to a mean of approximately 153 mmHg within the first 50 days. This historical data supports the current recommendation that treatment targets a systolic pressure below 160 mmHg, and ideally below 150 mmHg in cats with proteinuric chronic kidney disease.

## Monitoring Parameters and Their Clinical Significance

Monitoring the treated hypertensive cat serves three purposes: confirming that blood pressure has reached target, detecting recurrence of hypertension, and identifying progression of target organ damage. Blood pressure should be rechecked 7 to 10 days after initiating treatment or changing the dose. Once blood pressure is stable within the target range, recheck intervals can be extended to every 1 to 3 months depending on the severity of concurrent disease. Cats with chronic kidney disease and hypertension should be monitored at the shorter end of this range because of the dynamic interaction between renal function and blood pressure described in the [comorbidity review by Lawson and Jepson](https://pubmed.ncbi.nlm.nih.gov/34428941/).

Ophthalmologic examination should be repeated at every blood pressure recheck. The fundus is the most accessible window into hypertensive vascular injury, and improvement or progression of retinal lesions provides direct evidence of treatment efficacy. A cat with resolving retinal detachment or reattached retina may regain vision, whereas a cat with persistent retinal detachment despite adequate blood pressure control requires evaluation for other causes of vision loss.

Renal monitoring includes serial measurement of serum creatinine, symmetric dimethylarginine, and urine protein-to-creatinine ratio. Proteinuria should be assessed at diagnosis, at 1 month after treatment initiation, and then every 3 to 6 months. A rising urine protein-to-creatinine ratio in a cat with controlled blood pressure suggests progressive renal injury and may warrant additional intervention. The [biomarker study by Bijsmans and colleagues](https://pubmed.ncbi.nlm.nih.gov/28387019/) evaluated plasma vascular endothelial growth factor, N-terminal probrain natriuretic peptide, and cardiac troponin I as potential markers of hypertensive target organ damage, but concluded that none of these biomarkers functioned as useful diagnostic tests for hypertension in clinical practice. This finding reinforces the continued reliance on blood pressure measurement, fundic examination, and renal parameters for monitoring.

Cardiac monitoring in the hypertensive cat focuses on auscultation for murmurs, gallop rhythms, and arrhythmias. Echocardiography is indicated when a murmur is detected, when there is evidence of congestive heart failure, or when the cat has concurrent hyperthyroidism. The [feline hypertension diagnosis and management guidance from Stepien](https://pubmed.ncbi.nlm.nih.gov/21215947/) notes that hypertensive cardiac changes may be subtle and that thoracic auscultation alone is insufficient to exclude cardiac target organ damage.

## Documentation and Longitudinal Tracking

The medical record for a hypertensive cat should include the following elements at each visit: the blood pressure measurement technique used, the cuff size and site, the number of readings obtained, the average systolic pressure, the fundic examination findings, the body weight, the urine protein-to-creatinine ratio, and the current drug and dose. Serial blood pressure values should be plotted graphically or tabulated so that trends become apparent. A single reading of 170 mmHg in a cat that has been stable at 145 mmHg for six months is more concerning than a first reading of 170 mmHg in a newly diagnosed cat, and the trend should trigger a recheck within days instead of weeks.

The [ISFM consensus guidelines](https://pubmed.ncbi.nlm.nih.gov/28245741/) recommend that blood pressure be measured at least annually in all cats over 7 years of age, and at least every 6 months in cats with chronic kidney disease, hyperthyroidism, or a history of hypertension. Cats receiving antihypertensive treatment should never have their monitoring interval extended beyond 3 months without a documented period of stable blood pressure. When blood pressure remains consistently below 150 mmHg for 6 months or longer, the monitoring interval may be extended to 3 months, but it should not be extended further because hypertension in cats is a progressive condition that frequently requires dose adjustment over time.

## Adjusting the Monitoring Plan for Individual Patients

The monitoring schedule must be adapted to the individual cat's temperament, concurrent disease, and owner compliance. A fractious cat that requires heavy restraint for blood pressure measurement may benefit from home blood pressure monitoring using a validated device, with readings recorded by the owner and reviewed at clinic visits. However, home monitoring requires owner training and a cooperative cat, and the [feline hypertension diagnosis and management guidance from Stepien](https://pubmed.ncbi.nlm.nih.gov/21215947/) cautions that measurements obtained by untrained owners may be unreliable. In such cases, the clinician should prioritize clinic-based measurements and schedule shorter visits to minimize stress.

Cats with chronic kidney disease require more frequent monitoring of renal parameters than cats with primary hypertension. The [comorbidity review by Lawson and Jepson](https://pubmed.ncbi.nlm.nih.gov/34428941/) emphasizes that hypertension drives proteinuria, which in turn accelerates renal injury, creating a cycle that can be interrupted only by effective blood pressure control. A cat with stage 2 chronic kidney disease and hypertension should have serum biochemistry and urine protein-to-creatinine ratio checked at every blood pressure recheck, whereas a cat with primary hypertension and normal renal function may only need these tests every 6 months.

The monitoring plan should also account for changes in the cat's environment or health status. Hospitalization, surgery, or the addition of a new medication can transiently elevate blood pressure, and readings obtained during these periods should be interpreted with caution. A cat that develops new neurological signs, such as circling, head pressing, or seizures, requires immediate blood pressure measurement and fundic examination because hypertensive encephalopathy can progress rapidly to irreversible brain injury.

## Recognized Complications and Early Detection

The principal failure mode in feline hypertension is progression of target organ damage despite treatment. Ocular damage can progress silently between rechecks. A cat with initially normal fundic examination may develop retinal detachment within weeks if blood pressure control lapses. Early detection depends on scheduled fundic examination at every recheck, also when vision changes are reported. The ISFM consensus guidelines recommend that cats with hypertension be re-examined at regular intervals with blood pressure measurement and fundic assessment, since ocular lesions can develop or progress without owner-perceived signs [ISFM Consensus Guidelines on the Diagnosis and Management of Hypertension in Cats](https://pubmed.ncbi.nlm.nih.gov/28245741/).

Renal progression is more insidious. Proteinuria may increase before azotaemia worsens, and it independently predicts mortality in cats with chronic kidney disease [Feline comorbidities: The intermingled relationship between chronic kidney disease and hypertension](https://pubmed.ncbi.nlm.nih.gov/34428941/). Serial urine protein-to-creatinine ratio measurement detects this trend earlier than serum creatinine alone. Cardiac complications, including left ventricular hypertrophy and gallop rhythms, may develop or regress with blood pressure control, so auscultation and thoracic imaging should be repeated when clinical signs change.

Cerebrovascular events are the least predictable. Acute vestibular signs, behavioral change, or collapse in a hypertensive cat warrant immediate blood pressure measurement and fundic examination, as hypertensive encephalopathy may mimic other intracranial disease.

## Common Errors and Corrective Actions

Less experienced clinicians often attribute a single high reading to stress and defer treatment. The corrective action is to follow a standard measurement protocol, record multiple readings, and classify the cat using the risk thresholds from the ISFM guidelines instead of an informal impression [ISFM Consensus Guidelines on the Diagnosis and Management of Hypertension in Cats](https://pubmed.ncbi.nlm.nih.gov/28245741/).

A second error is treating the number instead of the patient. Blood pressure may remain mildly elevated while ocular lesions resolve, prompting unnecessary dose escalation. Conversely, a cat with normal blood pressure but progressive retinopathy may be undertreated. The monitoring plan must integrate blood pressure with target organ status.

A third error is inconsistent measurement technique between visits. Cuff size, site, and patient position affect readings. Using a different cuff or limb at each visit introduces artefact that mimics treatment failure. Standardizing the protocol and recording the conditions of measurement in the medical record prevents this.

A fourth error is neglecting proteinuria assessment after treatment begins. Antihypertensive therapy may lower blood pressure yet leave proteinuria unchanged, and persistent proteinuria carries independent prognostic weight [Feline comorbidities: The intermingled relationship between chronic kidney disease and hypertension](https://pubmed.ncbi.nlm.nih.gov/34428941/).

## Troubleshooting and Failure Modes

| Observation | Likely cause | Discriminating check |
| --- | --- | --- |
| Blood pressure high at recheck, no ocular lesions | Stress or white-coat effect | Repeat after acclimatisation, use multiple readings, compare with home environment if possible |
| Blood pressure controlled, new retinal detachment | Intermittent poor control between visits | Review owner compliance, consider 24-hour or home blood pressure assessment |
| Blood pressure controlled, proteinuria increasing | Progressive renal disease independent of hypertension | Serial UPC, renal ultrasound, biochemistry panel |
| Blood pressure refractory to amlodipine | Inadequate dose, poor absorption, or concurrent disease progression | Verify administration, reassess for hyperthyroidism or renal progression, consider adjuvant therapy per current formulary |
| Sudden blindness with normal blood pressure | Prior hypertensive episode now resolved, or non-hypertensive cause | Fundic examination for chronic retinal changes, rule out other ocular disease |

## Limitations of the Evidence and Areas of Expert Difference

The evidence base for feline hypertension monitoring rests largely on observational studies and consensus opinion. Randomised controlled trials comparing monitoring strategies are lacking. The ISFM guidelines acknowledge that blood pressure thresholds for intervention and target ranges are based on expert consensus instead of prospective outcome data [ISFM Consensus Guidelines on the Diagnosis and Management of Hypertension in Cats](https://pubmed.ncbi.nlm.nih.gov/28245741/). Whether a systolic target below 140 mmHg improves outcomes compared with a target below 160 mmHg remains unresolved.

Biomarker research has not yet produced a clinically useful diagnostic test. Studies of VEGF, NT-proBNP, and cardiac troponin I found statistically significant differences between hypertensive and normotensive cats, but these markers did not perform well enough as diagnostic tests to replace blood pressure measurement [Plasma N-Terminal Probrain Natriuretic Peptide, Vascular Endothelial Growth Factor, and Cardiac Troponin I as Novel Biomarkers of Hypertensive Disease and Target Organ Damage in Cats](https://pubmed.ncbi.nlm.nih.gov/28387019/). Their role in monitoring treatment response is similarly unproven.

Expert opinion differs on how aggressively to pursue blood pressure control in cats with concurrent chronic kidney disease. Some argue that lower blood pressure targets risk renal hypoperfusion, while others emphasize that uncontrolled hypertension drives renal injury. The ISFM guidelines recommend individualising targets based on the presence and progression of target organ damage [ISFM Consensus Guidelines on the Diagnosis and Management of Hypertension in Cats](https://pubmed.ncbi.nlm.nih.gov/28245741/).

## Referral and Escalation Criteria

Referral to a specialist is warranted when blood pressure remains uncontrolled despite appropriate amlodipine-based therapy, when target organ damage progresses despite apparent blood pressure control, or when the diagnosis of primary versus secondary hypertension is uncertain. Specialist evaluation may include advanced imaging, echocardiography, or endocrine testing beyond the scope of first-opinion practice.

Laboratory involvement is indicated for serial biochemistry, urinalysis, and UPC monitoring in all treated cats. A sudden rise in creatinine or potassium, or a marked increase in UPC, should prompt earlier recheck and investigation instead of waiting for the next scheduled visit.

Regulatory reporting is not typically required for feline hypertension. It is a spontaneous disease of companion animals, not a notifiable condition under international animal health standards [WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/). Clinicians should, however, be alert to the possibility of secondary hypertension from an undiagnosed primary disease and pursue that diagnosis instead of treating the blood pressure in isolation.

## Frequently Asked Questions

### How Often Should Blood Pressure Be Rechecked in a Cat with Stable Hypertension?

For a cat whose systolic blood pressure is consistently below the treatment target on a stable drug regimen, recheck every three months. This interval balances early detection of escape from blood pressure control against the practical limits of clinic visits. Cats that required dose adjustment, that have progressive chronic kidney disease, or that developed a new comorbidity such as hyperthyroidism should be rechecked at two to four weeks after any change, then at three months once stable. The [ISFM consensus guidelines on diagnosis and management of hypertension in cats](https://pubmed.ncbi.nlm.nih.gov/28245741/) emphasize that longitudinal monitoring is mandatory because blood pressure can rise again even after months of good control.

### What Can I Do When the Cat Will Not Tolerate Blood Pressure Measurement?

Do not record a value from a struggling or fractious cat. The reading will be falsely elevated and will drive wrong treatment decisions. Allow a ten to fifteen minute acclimation period in a quiet room. Use the smallest cuff that covers roughly thirty to forty percent of the limb circumference. If the cat remains intolerant, defer measurement and prescribe a short course of anxiolytic or sedative medication, then reattempt at the next visit. The [feline hypertension diagnosis and management review by Stepien](https://pubmed.ncbi.nlm.nih.gov/21215947/) notes that anxious or uncooperative patients remain a significant obstacle, and confident interpretation of results from these cats is difficult. Document the cat's demeanour and the measurement conditions on every occasion.

### How Do I Monitor Blood Pressure When Only an Oscillometric Device Is Available?

Oscillometric devices tend to read lower than Doppler in cats, especially at higher pressures, and they are more sensitive to movement and tachycardia. Use the same device for every measurement on that cat so trends remain comparable. Take five to seven consecutive readings, discard the highest and lowest, and average the remainder. If the oscillometric reading is borderline or inconsistent with the clinical picture, obtain a Doppler measurement if one can be arranged. The [ISFM consensus guidelines](https://pubmed.ncbi.nlm.nih.gov/28245741/) recommend that the chosen technique be reproducible and that the same method be used consistently for longitudinal monitoring.

### What Monitoring Is Needed for the Eyes of a Hypertensive Cat?

Perform a dilated funduscopic examination at diagnosis and at every recheck for the first three months. Thereafter, examine the fundus at each blood pressure recheck, roughly every three months. Resolution of retinal detachment, reattachment, and resorption of hemorrhage can lag behind blood pressure control by several weeks. The [clinical findings and treatment response study by Elliott and colleagues](https://pubmed.ncbi.nlm.nih.gov/11303854/) documented that amlodipine lowered systolic pressure substantially within fifty days, but ocular lesions may take longer to improve. Sudden blindness at presentation warrants weekly or biweekly fundic rechecks until the retina stabilizes. Photograph the fundus when possible to document progression objectively.

### How Should I Explain the Monitoring Plan to an Owner Who Is Worried about Cost?

Frame monitoring as the intervention that prevents blindness and slows kidney injury. A single episode of retinal detachment can cause irreversible vision loss, and the [feline comorbidities review by Lawson and Jepson](https://pubmed.ncbi.nlm.nih.gov/34428941/) highlights that hypertension drives proteinuria, an independent risk factor for CKD progression and mortality. Offer a tiered plan: essential monitoring includes blood pressure, urine protein-to-creatinine ratio, and fundic examination at each visit, while serum biomarker panels are optional. Explain that skipping rechecks risks a silent rise in pressure that only becomes apparent after target organ damage has occurred. Most owners accept three-month visits when the purpose is framed as preserving vision and kidney function.

### What Records Should I Keep for a Hypertensive Cat on Long-Term Treatment?

Maintain a dedicated flow sheet listing date, systolic blood pressure by the specific method used, cuff size, heart rate, body weight, fundic findings, urine protein-to-creatinine ratio, current drug and dose, and the cat's demeanour during measurement. Record the average of valid readings, not the single lowest value. Note any change in concurrent disease status, especially azotaemia or hyperthyroidism, because these alter blood pressure control. The [ISFM consensus guidelines](https://pubmed.ncbi.nlm.nih.gov/28245741/) stress that reproducible technique and consistent documentation underpin accurate diagnosis and therapeutic targeting. A structured record allows rapid recognition of treatment escape and supports defensible clinical decisions when the owner seeks a second opinion.

## Related Clinical & Scientific Guides

* [Canine Respiratory System: Anatomy and Physiology](/knowledge/veterinary-medicine/veterinary-anatomy-physiology/canine-respiratory-system-anatomy-physiology)
* [Comparative Anatomy of the Mammalian Kidney](/knowledge/veterinary-medicine/veterinary-anatomy-physiology/comparative-anatomy-mammalian-kidney)
* [Feline Cardiopulmonary Physiology: Heart-Lung Interactions](/knowledge/veterinary-medicine/veterinary-anatomy-physiology/feline-cardiopulmonary-physiology-heart-lung-interactions)


## References and Further Reading

- [ISFM Consensus Guidelines on the Diagnosis and Management of Hypertension in Cats.](https://pubmed.ncbi.nlm.nih.gov/28245741/). 2017.
- [Feline comorbidities: The intermingled relationship between chronic kidney disease and hypertension.](https://pubmed.ncbi.nlm.nih.gov/34428941/). 2021.
- [Feline systemic hypertension: Classification and pathogenesis.](https://pubmed.ncbi.nlm.nih.gov/21215946/). 2011.
- [Feline systemic hypertension: Diagnosis and management.](https://pubmed.ncbi.nlm.nih.gov/21215947/). 2011.
- [Feline hypertension: clinical findings and response to antihypertensive treatment in 30 cases.](https://pubmed.ncbi.nlm.nih.gov/11303854/). 2001.
- [Plasma N-Terminal Probrain Natriuretic Peptide, Vascular Endothelial Growth Factor, and Cardiac Troponin I as Novel Biomarkers of Hypertensive Disease and Target Organ Damage in Cats.](https://pubmed.ncbi.nlm.nih.gov/28387019/). 2017.
- [NCBI Bookshelf: Veterinary and Comparative Biomedical Sciences](https://www.ncbi.nlm.nih.gov/books/). NCBI Bookshelf.
- [MSD Veterinary Manual, Professional Edition](https://www.msdvetmanual.com/). MSD Veterinary Manual.
- [American Veterinary Medical Association Practice Resources](https://www.avma.org/resources-tools). American Veterinary Medical Association.

## Related Articles

- [Feline Cardiovascular Anatomy and Physiology](/knowledge/veterinary-medicine/veterinary-anatomy-physiology/feline-cardiovascular-anatomy-physiology)
- [Feline Cardiopulmonary Physiology: Heart-Lung Interactions](/knowledge/veterinary-medicine/veterinary-anatomy-physiology/feline-cardiopulmonary-physiology-heart-lung-interactions)
- [Feline Neuromuscular Physiology: Reflexes and Motor Control](/knowledge/veterinary-medicine/veterinary-anatomy-physiology/feline-neuromuscular-physiology-reflexes-motor-control)
- [Bovine Rumen Acidosis: Pathophysiology, Diagnosis, and Monitoring](/knowledge/veterinary-medicine/veterinary-anatomy-physiology/bovine-rumen-acidosis-pathophysiology-diagnosis-monitoring)
- [Feline Renal Anatomy and Physiology: A Clinical Correlation](/knowledge/veterinary-medicine/veterinary-anatomy-physiology/feline-renal-anatomy-physiology-clinical-correlation)

> This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.